验证数据展示
经过测试的应用
Positive WB detected in | mouse brain tissue |
Positive IHC detected in | human ovary cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
25029-1-AP targets PAG1 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
经测试应用 | WB, IHC, ELISA Application Description |
经测试反应性 | human, mouse |
免疫原 | PAG1 fusion protein Ag13393 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | phosphoprotein associated with glycosphingolipid microdomains 1 |
别名 | Phosphoprotein associated with glycosphingolipid-enriched microdomains 1, PAG, Csk-binding protein, Csk binding protein, CBP |
计算分子量 | 432 aa, 47 kDa |
观测分子量 | 50-60 kDa |
GenBank蛋白编号 | BC112159 |
基因名称 | PAG1 |
Gene ID (NCBI) | 55824 |
RRID | AB_2879858 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q9NWQ8 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
PAG1, also named as CBP and PAG, promotes CSK activation and recruitment to lipid rafts, which results in LCK inhibition. It is involved in cell adhesion signaling. PAG1 may play an important role in inhibiting the proliferation, invasion and metastasis of the cancer cells. PAG1 is a membrane protein with phosphor modification. The MW of PAG1 migrates to 50-65 kDa in WB detection.
实验方案
Product Specific Protocols | |
---|---|
WB protocol for PAG1 antibody 25029-1-AP | Download protocol |
IHC protocol for PAG1 antibody 25029-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |